0001104659-23-075030.txt : 20230627
0001104659-23-075030.hdr.sgml : 20230627
20230627084524
ACCESSION NUMBER: 0001104659-23-075030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230626
FILED AS OF DATE: 20230627
DATE AS OF CHANGE: 20230627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENTSUR RON
CENTRAL INDEX KEY: 0001251213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 231044158
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVE
STREET 2: 20TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2319737-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-26
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001251213
BENTSUR RON
C/O NUVECTIS PHARMA, INC.
1 BRIDGE PLAZA, SUITE 275
FORT LEE
NJ
07024
1
1
1
0
Chairman & CEO
0
Common Stock
2023-06-26
4
P
0
750
16.50
A
3230779
D
Includes 426,759 shares of restricted stock.
/s/ Ron Bentsur
2023-06-27